Aom 0187
Alternative Names: Aom-0187Latest Information Update: 04 Nov 2022
At a glance
- Originator Hangzhou Adamerck
- Class Eye disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Dry eyes
Most Recent Events
- 20 Oct 2022 Hangzhou Adamerck has patent protection and patents pending (Hangzhou Adamerck pipeline, October 2022)
- 20 Oct 2022 Early research in Dry eyes in China (unspecified route) (Hangzhou Adamerck pipeline, October 2022)